Delving into the Latest Updates on S303 Treated Red Blood Cells(Cerus) with Synapse

Overview

Basic Info

Drug Type

Cell therapy

Synonyms-

Target-

Action-

Mechanism

Cell replacements

Therapeutic Areas

Congenital DisordersHemic and Lymphatic DiseasesOther Diseases

Active Indication-

Inactive Indication

AnemiaBeta-Thalassemia

Originator Organization

Cerus Corp.

Active Organization-

Inactive Organization

Cerus Corp.

License Organization-

Drug Highest PhasePendingPhase 3

First Approval Date-

Regulation-

Login to view timeline

The clinical study will assess the in-vitro characteristics of red blood cells (RBCs) per the European Union (EU) criteria for leukocyte depleted RBCs in additive solution and evaluate the safety and efficacy of S-303 treated RBCs in a patient population requiring RBC transfusion support for acute anemia.

Start Date01 Apr 2013

Sponsor / Collaborator

Cerus Corp.

NCT01740531

/ CompletedPhase 3

A Randomized Controlled Study to Evaluate Efficacy and Safety of S 303 Treated Red Blood Cells (RBC) in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion

To evaluate the efficacy and safety of S 303 treated red blood cells (RBCs) in subjects who require chronic transfusion support due to thalassemia major.

Start Date01 Dec 2012

Sponsor / Collaborator

Cerus Corp.

NCT01711346

/ CompletedPhase 2

A Randomized, Controlled, Single-Blind, 2-Period Crossover Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells

The objective of this study is to assess the post-infusion viability of S-303 Red Blood Cells (RBC) by measuring the 24 hour post-infusion recovery and lifespan of autologous RBCs prepared with the S-303 Treatment System for RBC after storage for 35 days in comparison to conventional untreated RBCs stored for 35 days.

Start Date01 Oct 2012

Sponsor / Collaborator

Cerus Corp.

100 Clinical Results associated with S303 Treated Red Blood Cells(Cerus)

Login to view more data

100 Translational Medicine associated with S303 Treated Red Blood Cells(Cerus)

Login to view more data

100 Patents (Medical) associated with S303 Treated Red Blood Cells(Cerus)

Login to view more data

100 Deals associated with S303 Treated Red Blood Cells(Cerus)

Login to view more data